TrialPath
Recruiting

Polish Version Fatigue Severity Scale

NCT06668649 · Jagiellonian University
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Validation of Polish Language Version of Fatigue Severity Scale
About this study
Fatigue is one of main symptoms in multiple sclerosis, amyotrophic lateral sclerosis, post-polio syndrome, stroke, parkinsonism as well as in the chronic fatigue syndrome. It has profound effect on quality of life and professional and social functioning and in multiple sclerosis it is described as the worst symptoms by the 50% of patients. It is defined as the difficulty in initiating and maintaining a sustained mental or physical activity. Not infrequent it is misdiagnosed as sleepiness or other symptom. Fatigue severity scale (FSS) is a time efficient and easy to apply instrument to assess the impact of fatigue on patient's life. It has been translated and validated in Turkish, Russian, Hindi, Portuguese, and many other languages. FSS is a short, nine-item self-report questionnaire. Each item is a Likert scale, scored from one to seven, where seven refers to the most severely expressed aspect of fatigue. The aim of this study is to validate the Polish-language version of the Fatigue Severity Scale (pFSS). This version has been created according to widely accepted, respective standards, including translation by two independent native Polish-language speakers with acquired knowledge of English and backward translation by two independent native English-language speakers with acquired knowledge of Polish as well as with the pretesting on ten patients.
Eligibility criteria
Inclusion Criteria: * Diagnosis of definite multiple sclerosis or definite, laboratory-supported multiple sclerosis, or definite amyotrophic lateral sclerosis, or probable amyotrophic lateral sclerosis or probable, laboratory supported amyotrophic lateral sclerosis or ischemic stroke or - for healthy controls - lack of diseases, pharmacotherapy or habits, which could induce abnormal tiredness Exclusion Criteria: * Presence of cognitive deficits or behavioral disorder, which could disturb participation in the study.
Study design
Enrollment target: 310 participants
Age groups: adult, older_adult
Timeline
Starts: 2024-11-04
Estimated completion: 2027-03-31
Last updated: 2024-11-08
Interventions
Diagnostic Test: Testing with Questionnaires
Primary outcomes
  • • Internal Consistency (Through study completion, an average of 1 year)
  • • Validity (Through study completion, an average of 1 year)
  • • Reliability (Through study completion, an average of 1 year)
Sponsor
Jakub Antczak · other
With: Institute of Psychiatry and Neurology, Warsaw
Contacts & investigators
ContactJakub M Antczak, MD · contact · jakub.antczak@uj.edu.pl · +48 12 400 25 50
ContactGabriela G Rusin, MD · contact · gabriela.rusin@alumni.uj.edu.pl · +48 12 400 25 50
InvestigatorJakub M Antczak, MD · principal_investigator, Jagiellonian University
All locations (2)
Jagiellonian University Medical College, Department of NeurologyRecruiting
Krakow, Lesser Poland Voivodeship, Poland
Institute of Psychiatry and NeurologyRecruiting
Warsaw, Poland
Polish Version Fatigue Severity Scale · TrialPath